Literature DB >> 20883201

A QSAR study of HIV protease inhibitors using theoretical descriptors.

Subhash C Basak1, Denise Mills, Rajni Garg, Barun Bhhatarai.   

Abstract

This paper reports the development of quantitative structure-activity relationship (QSAR) models for a set of 170 chemicals using mathematical descriptors which can be calculated directly from molecular structure without the input of any other experimental data. The calculated descriptors include topostructural (TS), topochemical (TC), and quantum chemical (QC). Because the situation is rank deficient i.e. the number of independent variables (descriptors) is larger than the number of compounds, three robust linear statistical modeling methods capable of handling such situations, viz., principal components regression (PCR), partial least square (PLS), and ridge regression (RR) were used for QSAR formulation. Results show that PLS and RR gave better q2 values as compared to the PCR method. Of the three classes of descriptors, the TC indices were the best predictors of anti-HIV activity and the QC indices were the least effective.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20883201     DOI: 10.2174/1573409911006040269

Source DB:  PubMed          Journal:  Curr Comput Aided Drug Des        ISSN: 1573-4099            Impact factor:   1.606


  3 in total

1.  QSAR modeling, docking and ADMET studies for exploration of potential anti-malarial compounds against Plasmodium falciparum.

Authors:  Tabish Qidwai
Journal:  In Silico Pharmacol       Date:  2017-07-19

2.  HIVprotI: an integrated web based platform for prediction and design of HIV proteins inhibitors.

Authors:  Abid Qureshi; Akanksha Rajput; Gazaldeep Kaur; Manoj Kumar
Journal:  J Cheminform       Date:  2018-03-09       Impact factor: 5.514

3.  AVCpred: an integrated web server for prediction and design of antiviral compounds.

Authors:  Abid Qureshi; Gazaldeep Kaur; Manoj Kumar
Journal:  Chem Biol Drug Des       Date:  2016-09-09       Impact factor: 2.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.